Cargando…

Anticoagulation in patients with mechanical heart valves: follow the guidelines!

Detalles Bibliográficos
Autor principal:	Verheugt, Freek W.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2015
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315795/ https://www.ncbi.nlm.nih.gov/pubmed/25605555 http://dx.doi.org/10.1007/s12471-014-0642-9

Ejemplares similares

Trials, registries and guidelines for non-ST-elevation acute coronary syndromes
por: Verheugt, F. W. A.
Publicado: (2013)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001)

Commentary on the association of blood group antigens with post-implant thrombosis of mechanical heart valves
por: Pourafkari, Leili, et al.
Publicado: (2016)

Anticoagulation for the Pregnant Patient with a Mechanical Heart Valve, No Perfect Therapy: Review of Guidelines for Anticoagulation in the Pregnant Patient
por: Richardson, Aaron, et al.
Publicado: (2017)

Minimally Invasive Delivery of Tissue Engineered Heart Valves to the Pulmonary Annulus
por: Roche, Ellen T.
Publicado: (2020)

Heart failure guidelines implementation: Lifting barriers using registries and networks
por: Keramida, Kalliopi, et al.
Publicado: (2020)

Postpartum anticoagulation in women with mechanical heart valves
por: Irani, Roxanna A, et al.
Publicado: (2018)

Unbreak My Heart (Valve): Can Ultrasound Be Used for the Treatment of a Degenerated Surgical Bioprosthesis?
por: Sinning, Jan-Malte, et al.
Publicado: (2017)

The role of valve interstitial cells in valve disease
por: Feng, Yang, et al.
Publicado: (2016)

Valve implantations on the move
por: Wiegerinck, E. M. A., et al.
Publicado: (2014)

Anticoagulation in COVID-19
por: Bradbury, Charlotte A, et al.
Publicado: (2022)

Subject- and Leaflet-Specific Remodeling of Polymeric Heart Valves for In Situ Tissue Engineering: Challenges Towards Clinical Translation
por: Mela, Petra
Publicado: (2020)

Non vitamin K anticoagulation drugs will win the race
por: Van Gelder, I. C., et al.
Publicado: (2016)

Novel oral anticoagulants: the translation of ‘de Leidraad’ into daily clinical practice
por: Jaspers Focks, J., et al.
Publicado: (2014)

Direct oral anticoagulant failure in stroke/transient ischaemic attack: neurologic and pharmacokinetic considerations
por: Rose, David Z, et al.
Publicado: (2020)

Catheter-Based Intervention of the “Forgotten” Valve: Time to Reconsider Tricuspid Valve Intervention?
por: Granada, Juan F., et al.
Publicado: (2018)

Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade
por: Atar, Dan, et al.
Publicado: (2014)

Tricuspid Regurgitation, Isn't It Time to Look Around the Valve Rather Than the Valve Itself?
por: Lee, Seung-Pyo
Publicado: (2015)

Guidance on guideline adherence
por: Peters, R.J.G.
Publicado: (2015)

Heterotopic Transcatheter Tricuspid Valve Implantation: A Useful Bailout Strategy After Failed Transcatheter Tricuspid Valve Repair?
por: Sticchi, Alessandro, et al.
Publicado: (2022)

Direct Effects of Activation and Inhibition of the Coagulation System on the Atrial Fibrillation Substrate: Is Anticoagulation Antiarrhythmic?
por: Nattel, Stanley
Publicado: (2016)

Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves
por: Kuramatsu, Joji B, et al.
Publicado: (2018)

Mitral valve prolapse: a source of arrhythmias?
por: van der Wall, E. E., et al.
Publicado: (2009)

Unraveling the Mechanisms by Which Calpain Inhibition Prevents Heart Failure Development
por: Wehrens, Xander H.T.
Publicado: (2018)

The role of aspirin in women’s health
por: Verheugt, Freek WA, et al.
Publicado: (2011)

Response to editorial comment ‘Direct oral anticoagulant failure in TIA/stroke: neurologic and pharmacokinetic considerations’
por: Huynh, Ronald, et al.
Publicado: (2020)

Anticoagulation in COVID-19: reaction to the ACTION trial
por: Berger, Jeffrey S, et al.
Publicado: (2021)

PCSK9 and Calcific Aortic Valve Stenosis: Moving Beyond Lipids
por: Leopold, Jane A.
Publicado: (2020)

Empagliflozin and Protecting Microvascular Support of Heart Mechanics: SGLT2 Inhibition or More?
por: Mantsounga, Chris Sorel, et al.
Publicado: (2019)

Off Target But on Track to New Strategies to Mitigate Calcific Aortic Valve Disease
por: Towler, Dwight A.
Publicado: (2019)

Robotic surgical ablation of atrial fibrillation in mitral valve surgery
por: Akar, Ahmet Rüçhan
Publicado: (2021)

Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description
por: Berndt, Nadine, et al.
Publicado: (2012)

Vocational challenges in congenital heart disease
por: Helbing, W. A., et al.
Publicado: (2014)

Bladder dysfunction depends on many variables in children with posterior urethral valves
por: de Jesus, Lisieux Eyer
Publicado: (2021)

Abnormal heart rate recovery in patients with heart failure: an important target for exercise training treatment
por: Dimopoulos, Stavros
Publicado: (2015)

Paradoxical Cardiorenal Responses Following Acute Vasodilator/Natriuretic Treatment in Presystolic Heart Failure: Should We Be Surprised?
por: Polonsky, Tamar S., et al.
Publicado: (2019)

Lipoprotein(a): A Taxi for Autotaxin Takes a Toll in Calcific Aortic Valve Disease
por: Towler, Dwight A.
Publicado: (2017)

A call for re-evaluation of the guidelines for prophylactic ICD implantation
por: Luermans, J. G. L. M., et al.
Publicado: (2014)

Takotsubo cardiomyopathy – stunning views on the broken heart
por: Teske, A. J., et al.
Publicado: (2016)

Pulmonary hypertension in the changing landscape of congenital heart disease: Global differences and a possible driver of end-stage heart failure
por: Van De Bruaene, A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_arc7715l5t2h97vsfthio874gb